OR WAIT null SECS
February 11, 2014
EMA and the European Commission revise Q&A document on implementation of marketing authorization guidelines.
February 02, 2014
High technology assessments are having an impact on biosimilars development in Europe.
January 30, 2014
EMA's guidance focuses on the use of pharmacogenomics to improve drug safety monitoring.
November 26, 2013
European Medicines Agency announces the launch of the Accelerated development of vaccine benefit-risk collaboration in Europe (ADVANCE) project.
November 07, 2013
Includes a new approach on developing antibacterial agents targeted against multidrug-resistant (MDR) pathogens where patients have very limited or no remaining treatment options.
November 02, 2013
Regulators hope new standards will stop illegal drug imports, but manufacturers fear they may stifle innovation.
September 30, 2013
EMA revises HIV treatment guideline.
September 17, 2013
EMA releases details of restructuring.
September 02, 2013
The aim of the European Falsified Medicines Directive is to improve the quality of imported APIs, but does the pain now outweigh the gain?
August 20, 2013
Agencies collaborate to ensure consistent product quality.